You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 135 No. 2, February 1999 TABLE OF CONTENTS
  Archives
  •  Online Features
  Study
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (37)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Immunologic Disorders
 •Bullous Diseases
 •Pemphigus
 •Alert me on articles by topic

Desmoglein 3-ELISA

A Pemphigus Vulgaris–Specific Diagnostic Tool

Petra Lenz, MD; Masayuki Amagai, MD; Beatrix Volc-Platzer, MD; Georg Stingl, MD; Reinhard Kirnbauer, MD

Arch Dermatol. 1999;135:143-148.

Background  Pemphigus vulgaris (PV) is an autoimmune-blistering disease of the skin and mucous membranes caused by autoantibodies against desmoglein 3 (Dsg3), an epidermal desmosomal adhesion protein of the cadherin family. Cloning of the Dsg3 gene and expression of the protein in a native conformation enabled the recent development of a specific and sensitive enzyme-linked immunosorbent assay (ELISA) for the detection of PV autoantibodies.

Objectives  To evaluate serum samples from patients with PV and other dermatologic diseases for anti-Dsg3 antibodies. To compare ELISA values with autoantibody titers obtained by classic indirect immunofluorescence (IIF).

Design  Serum samples from patients with PV and various other bullous and nonbullous skin diseases were tested for anti-Dsg3 reactivity by ELISA.

Setting  Ambulatory and hospitalized patients from a university hospital.

Patients  Fifty-two serum samples from 11 patients with PV, and serum samples from 11 patients with bullous pemphigoid, 12 patients with other bullous diseases, 22 patients with various nonbullous skin disorders, and 10 healthy individuals were tested.

Results  Forty-seven (98%) of 48 serum samples from patients with PV that were positive by IIF on monkey esophagus were also reactive by Dsg3-ELISA, whereas 4 of 4 IIF-negative PV serum samples showed no reactivity by ELISA. In addition, negative ELISA results were obtained from 11 of 11 serum samples from patients with bullous pemphigoid, 10 of 12 serum samples from patients with other bullous skin disorders, 7 of 9 serum samples from patients with autoimmune-connective tissue diseases, and 13 of 13 serum samples from patients with other nonbullous skin diseases. Interestingly, 1 patient with paraneoplastic pemphigus had positive ELISA results. There was a positive correlation (r = 0.654) between ELISA values and IIF titers within the whole population with PV. In addition, when multiple serum samples from 1 patient with PV sampled over a 2-year period were tested, ELISA reactivity paralleled both the IIF titers and the clinical course.

Conclusion  The Dsg3-ELISA is a sensitive, objective, and PV-specific test that should be considered as an adjunct test for the management of patients with PV.


From the Laboratory of Viral Oncology, the Division of Immunology, Allergy, and Infectious Diseases, Department of Dermatology, University of Vienna Medical School, Vienna, Austria (Drs Lenz, Volc-Platzer, Stingl, and Kirnbauer); and the Department of Dermatology, Keio University School of Medicine, Tokyo, Japan (Dr Amagai).


RELATED ARTICLES

Desmoglein ELISAs: A Novel Diagnostic Tool for Pemphigus
Takeji Nishikawa
Arch Dermatol. 1999;135(2):195-196.
EXTRACT | FULL TEXT  

Archives of Dermatology Reader's Choice: Continuing Medical Education
Arch Dermatol. 1999;135(2):226-227.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Plant Lectin Wheat Germ Agglutinin Inhibits the Binding of Pemphigus Foliaceus Autoantibodies to Desmoglein 1 in a Majority of Patients and Prevents Pathomechanisms of Pemphigus Foliaceus In Vitro and In Vivo
Ortiz-Urda et al.
J. Immunol. 2003;171:6244-6250.
ABSTRACT | FULL TEXT  

Limitations in Enzyme-linked Immunosorbent Assays for Antibodies Against Desmogleins 1 and 3 in Patients With Pemphigus
Bystryn et al.
Arch Dermatol 2002;138:1252-1253.
FULL TEXT  

Classification, Clinical Manifestations, and Immunopathological Mechanisms of the Epithelial Variant of Paraneoplastic Autoimmune Multiorgan Syndrome: A Reappraisal of Paraneoplastic Pemphigus
Nguyen et al.
Arch Dermatol 2001;137:193-206.
ABSTRACT | FULL TEXT  

Advances in Laboratory Evaluation of Pemphigus Vulgaris
Gaspari
Arch Dermatol 1999;135:1418-1418.
FULL TEXT  

Desmoglein ELISAs: A Novel Diagnostic Tool for Pemphigus
Nishikawa
Arch Dermatol 1999;135:195-196.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.